Max Healthcare (MAXHEALTH) | Financial Analysis & Statements
Max Healthcare Institute Ltd. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
20.3B
Gross Profit
15.8B
78.04%
Operating Income
4.2B
20.65%
Net Income
3.1B
15.19%
EPS (Diluted)
₹3.15
Balance Sheet Metrics
Total Assets
152.1B
Total Liabilities
58.3B
Shareholders Equity
93.8B
Debt to Equity
0.62
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Max Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 69.1B | 53.1B | 44.9B | 38.8B | 24.8B |
| Cost of Goods Sold | 14.8B | 11.2B | 9.2B | 9.2B | 5.9B |
| Gross Profit | 54.3B | 41.9B | 35.7B | 29.6B | 18.9B |
| Gross Margin % | 78.6% | 78.9% | 79.5% | 76.2% | 76.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 18.2B | 13.8B | 11.8B | 9.5B | 6.4B |
| Other Operating Expenses | 5.8B | 4.0B | 3.4B | 2.7B | 2.1B |
| Total Operating Expenses | 24.1B | 17.8B | 15.3B | 12.2B | 8.4B |
| Operating Income | 15.8B | 13.0B | 10.5B | 7.9B | 2.9B |
| Operating Margin % | 22.8% | 24.4% | 23.3% | 20.4% | 11.6% |
| Non-Operating Items | |||||
| Interest Income | 1.2B | 1.6B | 1.1B | 750.9M | 767.3M |
| Interest Expense | 1.5B | 445.6M | 713.2M | 900.1M | 1.7B |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 14.1B | 13.7B | 10.6B | 7.4B | -686.5M |
| Income Tax | 3.3B | 3.1B | -397.9M | 1.3B | 458.5M |
| Effective Tax Rate % | 23.5% | 22.5% | -3.7% | 18.1% | 0.0% |
| Net Income | 10.8B | 10.6B | 11.0B | 6.1B | -1.4B |
| Net Margin % | 15.6% | 19.9% | 24.6% | 15.6% | -5.5% |
| Key Metrics | |||||
| EBITDA | 20.5B | 16.9B | 13.8B | 10.8B | 5.5B |
| EPS (Basic) | ₹11.07 | ₹10.89 | ₹11.38 | ₹6.25 | ₹-1.59 |
| EPS (Diluted) | ₹11.01 | ₹10.84 | ₹11.36 | ₹6.24 | ₹-1.59 |
| Basic Shares Outstanding | 972036067 | 971566374 | 970063788 | 967465373 | 863195968 |
| Diluted Shares Outstanding | 972036067 | 971566374 | 970063788 | 967465373 | 863195968 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Max Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 6.6B | 9.8B | 13.7B | 3.1B | 6.3B |
| Short-term Investments | 1.1M | 1.6B | 12.4B | 1.7B | 2.0M |
| Accounts Receivable | 6.9B | 4.6B | 3.4B | 3.9B | 3.7B |
| Inventory | 1.1B | 798.4M | 762.3M | 613.6M | 538.0M |
| Other Current Assets | 486.5M | 191.2M | 163.3M | 215.8M | 179.1M |
| Total Current Assets | 15.9B | 17.1B | 19.4B | 10.0B | 11.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 19.3B | 13.5B | 9.1B | 7.8B | 6.9B |
| Goodwill | 95.2B | 85.4B | 75.2B | 75.7B | 72.4B |
| Intangible Assets | 25.6B | 26.3B | 26.1B | 26.6B | 23.3B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.7B | 3.6B | 100.0K | -100.0K | 2.2B |
| Total Non-Current Assets | 136.2B | 102.9B | 81.6B | 81.9B | 74.2B |
| Total Assets | 152.1B | 120.0B | 101.0B | 91.9B | 85.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 8.1B | 6.8B | 5.4B | 4.4B | 4.4B |
| Short-term Debt | 2.4B | 1.2B | 904.7M | 1.2B | 886.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 56.9M | 60.1M | 60.1M | 146.6M | 645.4M |
| Total Current Liabilities | 18.1B | 12.5B | 10.5B | 7.6B | 7.8B |
| Non-Current Liabilities | |||||
| Long-term Debt | 27.7B | 13.9B | 8.2B | 10.2B | 12.4B |
| Deferred Tax Liabilities | 6.5B | 5.1B | 4.4B | 6.8B | 5.8B |
| Other Non-Current Liabilities | 2.7B | 2.6B | 2.4B | 2.4B | 2.4B |
| Total Non-Current Liabilities | 40.2B | 23.4B | 16.5B | 21.5B | 21.3B |
| Total Liabilities | 58.3B | 35.9B | 26.9B | 29.1B | 29.1B |
| Equity | |||||
| Common Stock | 9.7B | 9.7B | 9.7B | 9.7B | 9.7B |
| Retained Earnings | 31.1B | 21.9B | 12.3B | 1.4B | -4.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 93.8B | 84.1B | 74.1B | 62.8B | 56.4B |
| Key Metrics | |||||
| Total Debt | 30.1B | 15.1B | 9.1B | 11.4B | 13.3B |
| Working Capital | -2.2B | 4.6B | 9.0B | 2.4B | 3.5B |
Balance Sheet Composition
Max Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 14.1B | 13.7B | 10.6B | 7.4B | -686.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 545.9M | 496.2M | 343.6M | 339.3M | 265.1M |
| Working Capital Changes | -2.4B | -1.3B | 496.6M | -905.9M | 931.0M |
| Operating Cash Flow | 13.0B | 11.9B | 11.2B | 7.1B | 3.6B |
| Investing Activities | |||||
| Capital Expenditures | -9.6B | -7.7B | -3.3B | -5.5B | -1.2B |
| Acquisitions | -6.2B | -6.3B | -4.8M | -1.1B | 0 |
| Investment Purchases | -7.7M | -12.6M | -968.1M | -1.7B | 0 |
| Investment Sales | - | - | 997.1M | - | - |
| Investing Cash Flow | -14.8B | -14.4B | -1.4B | -8.3B | -1.2B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -1.5B | -970.1M | - | - | - |
| Debt Issuance | 13.5B | 6.3B | 70.7M | 365.6M | 7.4B |
| Debt Repayment | -10.5B | -5.6B | -1.4B | -2.5B | -8.3B |
| Financing Cash Flow | 1.5B | -179.4M | -1.6B | -1.9B | 3.9B |
| Free Cash Flow | 4.9B | 3.4B | 9.5B | 1.9B | -5.6M |
| Net Change in Cash | -292.2M | -2.7B | 8.3B | -3.1B | 6.3B |
Cash Flow Trend
Max Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
68.81
Forward P/E
47.64
Price to Book
9.77
Price to Sales
11.99
PEG Ratio
2.65
Profitability Ratios
Profit Margin
17.43%
Operating Margin
20.66%
Return on Equity
11.47%
Return on Assets
7.07%
Financial Health
Current Ratio
0.79
Debt to Equity
32.58
Beta
0.15
Per Share Data
EPS (TTM)
₹14.58
Book Value per Share
₹102.71
Revenue per Share
₹83.73
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MAXHEALTH | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Fortis Healthcare | 699.7B | 72.46 | 7.40 | 8.44% | 10.94% | 32.96 |
| Narayana Hrudayalaya | 365.2B | 46.80 | 8.99 | 21.78% | 11.49% | 57.61 |
| Aster DM Healthcare | 364.6B | 110.37 | 8.03 | 147.28% | 7.33% | 43.79 |
| Global Health | 298.6B | 58.23 | 8.08 | 14.21% | 12.29% | 25.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.





